Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Strontium ranelate plus vitamin D3 for osteoporotic patients with vitamin D insufficiency
ISRCTN59279012Phase 3Completed
- Sponsor
- Servier
- Start
- Jan 2010
- Modality
- Small Molecules, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules
01
Overview
Phase 3, randomised trial of strontium ranelate and vitamin d in osteoporosis and Vitamin D deficiency (VDD) (2 arms), sponsored by Servier. Primary endpoint: Serum 25-OH vitamin D3 levels at 3 months. Started Jan 2010; status: completed.
02
Drugs
strontium ranelatevitamin d
03
Conditions
osteoporosisVitamin D deficiency (VDD)
Beyond the preview
Go deeper on ISRCTN59279012.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ISRCTN59279012.